Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 100 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT00091871
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06477653
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07323654
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Kymera Investigative Site Lancaster, California, United States
- Kymera Investigative Site Long Beach, California, United States
- Kymera Investigative Site Northridge, California, United States
- Kymera Investigative Site Redding, California, United States
Recruiting
SIM0718 Treatment of Asthma Clinical Study
NCT06488755
- Conditions
- Asthma; Eosinophilic, Eosinophilia, Hematologic Diseases, +6 more
- Locations
-
- China Japan Friendship Hospital Beijing, Beijing Municipality, China
NCT04018118
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Hôpital Roger Salengro, CHU Lille, France
Recruiting
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
NCT03801434
- Conditions
- BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, +17 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- University of Utah Salt Lake City, Utah, United States
- Fred Hutchinson cancer research center Seattle, Washington, United States
NCT07275190
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +18 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo, SC Reumatologia Pavia, Italy
NCT05334368
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site Southfield, Michigan, United States
NCT02760238
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +34 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT04565483
- Conditions
- Asthma, Asthma; Eosinophilic, Bronchial Diseases, +14 more
- Locations
-
- Centre hospitalier Intercommunal Aix-en-Provence Aix-en-Provence, France
- CHU Angers Angers, France
- CHU Bordeaux Bordeaux, France
- CHRU Brest Brest, France
NCT02852928
- Conditions
- Child, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eosinophilia, +18 more
- Locations
-
- Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
- Hacettepe University, Medical Faculty Ankara, Sihhiye, Turkey (Türkiye)
- University of Edinburgh Edinburgh, United Kingdom
NCT04538937
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +24 more
- Locations
-
- University Clinic for Internal Medicine II Innsbruck, Austria
Enrolling by Invitation
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
NCT07343661
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +28 more
- Locations
-
- Policlinico Duilio Casula AOU Cagliari Cagliari, Italy
Not Yet Recruiting
Fasenra: An Asthma Study
NCT07654842
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +15 more
- Locations
-
- Endeavor Health Skokie, Illinois, United States
Not Yet Recruiting
A Study of Depemokimab in Participants of 6 to 11 Years of Age
NCT07671001
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +26 more
- Locations
-
Not specified
Not Yet Recruiting
A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma
NCT07250594
- Conditions
- Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
- Locations
-
- Advagene Biopharma Taipei, Taiwan
Not Yet Recruiting
REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)
NCT07174713
- Conditions
- Airway Remodeling, Asthma; Eosinophilic, Eosinophilia, +9 more
- Locations
-
- Robarts Research Institute; The University of Western Ontario London, Ontario, Canada
Not Yet Recruiting
Eosinophil Subpopulations in Eosinophilic-associated Diseases
NCT06911775
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +22 more
- Locations
-
Not specified
Not Yet Recruiting
Homeostatic Roles of Eosinophils in Asthma
NCT06676397
- Conditions
- Asthma; Eosinophilic, Eosinophilia, Hematologic Diseases, +6 more
- Locations
-
Not specified